DOP70 Anti-TNF withdrawal according to a risk-stratified protocol does not reduce the risk of relapse in patients with Inflammatory Bowel Disease in endoscopic remission: A prospective study
Remi Mahmoud(University Medical Center Utrecht), Bas Oldenburg(University Medical Center Utrecht), D Akol-Simsek, Frank Hoentjen(Radboud University Nijmegen), P van Boeckel(St. Antonius Ziekenhuis), Itta M. Minderhoud(Tergooi), Eelco J.P. de Koning(Leiden University Medical Center), Ben Witteman(Ziekenhuis Gelderse Vallei), Carmen S. Horjus(Rijnstate Hospital), Nofel Mahmmod(St. Antonius Ziekenhuis), Maurice Lutgens(Elisabeth-TweeSteden Ziekenhuis), Edo Savelkoul(Radboud University Nijmegen), Rogier Goetgebuer(Erasmus MC), Bindia Jharap(Meander Medisch Centrum), Tessa E H Römkens(Jeroen Bosch Ziekenhuis), Jeroen M. Jansen(OLVG), Wout Mares(Ziekenhuis Gelderse Vallei), Sebastiaan V. Tuyl(Diakonessenhuis hospital)
Cited by 0
Related Papers
Endoscopic or surgical step-up approach for infected necrotising pancreatitis: a multicentre randomised trial
|The Lancet|2017|732
Loss of Response to Anti-TNFs: Definition, Epidemiology, and Management
|Clinical and Translational Gastroenterology|2016|724
Unlimited in vitro expansion of adult bi‐potent pancreas progenitors through the Lgr5/R‐spondin axis
|The EMBO Journal|2013|721
Colonic stenting versus emergency surgery for acute left-sided malignant colonic obstruction: a multicentre randomised trial
|The Lancet Oncology|2011|470
Associations of Abdominal Subcutaneous and Visceral Fat with Insulin Resistance and Secretion Differ Between Men and Women: The Netherlands Epidemiology of Obesity Study
|Metabolic Syndrome and Related Disorders|2018|313